THE APPLICATION OF A NOVEL BIOTINYLATED AFFINITY LABEL FOR THE DETECTION OF A CATHEPSIN-B-LIKE PRECURSOR PRODUCED BY BREAST-TUMOR CELLS IN CULTURE

被引:27
作者
CULLEN, BM
HALLIDAY, IM
KAY, G
NELSON, J
WALKER, B
机构
[1] QUEENS UNIV BELFAST,SCH BIOL & BIOCHEM,DIV BIOCHEM,BELFAST BT9 7BL,ANTRIM,NORTH IRELAND
[2] INST CLIN SCI,DEPT SURG,BELFAST BT12 6BJ,ANTRIM,NORTH IRELAND
关键词
D O I
10.1042/bj2830461
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this report we demonstrate how the recently developed biotinylated affinity label biotinyl-Phe-Ala-diazomethane (Bio-Phe-Ala-CHN2) [Cullen. McGinty, Walker, Nelson, Halliday, Bailie & Kay (1990) Biochem. Soc. Trans. 18, 315 316; Walker, Cullen, Kay, Halliday, McGinty & Nelson (1992) Biochem. J. 283, 449 453] can be used for the detection of a precursor form of a cathepsin B-like enzyme produced by breast-tumour cells in culture. Thus the cell lines MDA-MB436, ZR-75-1 and T47-D produce a soluble protein that can be allowed to react with the biotinylated affinity label to yield an SDS-resistant complex; this can be revealed with a streptavidin/alkaline phosphatase label after PAGE and Western blotting. This protein (molecular mass 47 kDa) can also be detected by immunoblotting using sheep anti-(cathepsin B) antibodies in conjunction with a donkey anti-sheep IgG label. None of the cell lines studied produced any mature cathepsin B-like activity, as gauged by the lack of turnover of the fluorogenic substrate benzyloxycarbonyl-Arg-Arg-4-methylcoumarin-7-ylamide (Cbz-Arg-Arg-NH-Mec). However, treatment of medium samples with pepsin resulted in the generation of such activity. When the pepsin-catalysed activation step was analysed by SDS/PAGE. the protein of 47 kDa was completely converted into two species of verv similar molecular masses of 30.5 kDa and 29 kDa. Both these proteins can incorporate the biotinylated probe and, in common with the 47 kD species, they can be detected with the streptavidin/alkaline phosphatase label and immunoblotting. We propose that the 47 kD form is the pepsin-activable proform of these lower-molecular-mass species. The release of the proform from the oestrogen-receptor (ER)-positive breast-tumour cell lines ZR-75-1 and T47-D is stimulated 5 10-fold when these cells are grown in medium containing epidermal growth factor (EGF) at a concentration of 10 ng/ml. In contrast, there is no modulation in the amount of proform released by the ER-negative cell line MDA-MB-436, over a range of EGF concentrations from 0 to 100 ng/ml.
引用
收藏
页码:461 / 465
页数:5
相关论文
共 30 条
  • [1] BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535
  • [2] CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911
  • [3] SYNTHESIS AND ACTIVITY OF A NOVEL, IRREVERSIBLE INHIBITOR OF CATHEPSIN-B
    CULLEN, BM
    MCGINTY, A
    WALKER, B
    NELSON, J
    HALLIDAY, I
    BAILIE, JR
    KAY, G
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1990, 18 (02) : 315 - 316
  • [4] ENGEL LW, 1978, CANCER RES, V38, P3352
  • [5] THE MAJOR EXCRETED PROTEIN (MEP) OF TRANSFORMED MOUSE CELLS AND CATHEPSIN-L HAVE SIMILAR PROTEASE SPECIFICITY
    GAL, S
    GOTTESMAN, MM
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 139 (01) : 156 - 162
  • [6] GAL S, 1986, J BIOL CHEM, V261, P1760
  • [7] GREEN GDJ, 1981, J BIOL CHEM, V256, P1923
  • [8] HANEWINKEL H, 1987, J BIOL CHEM, V262, P12351
  • [9] PRODUCTION OF TRANSFORMING GROWTH FACTOR-ALPHA IN HUMAN-TUMOR CELL-LINES
    IMANISHI, K
    YAMAGUCHI, K
    SUZUKI, M
    HONDA, S
    YANAIHARA, N
    ABE, K
    [J]. BRITISH JOURNAL OF CANCER, 1989, 59 (05) : 761 - 765
  • [10] KEPPLER D, 1988, BIOL CHEM H-S, V369, P185